Christophe Le Terrier

Christophe Le Terrier is a Researcher in the Department of Medicine at the Faculty of Science and Medicine, University of Fribourg. His work focuses on antibiotic resistance mechanisms, ICU patient outcomes, and antimicrobial susceptibility testing. He has contributed to studies on novel β-lactamase inhibitors, critical care protocols, and the impact of microbiota diversity on mortality in critically ill patients.

Research interests include:

• Antibiotic resistance in Enterobacterales and Pseudomonas aeruginosa
• β-Lactamase inhibitor efficacy (e.g., taniborbactam, xeruborbactam)
• Critical care interventions for ARDS and ventilator-associated pneumonia
• Microbiome dynamics in critically ill populations

His recent studies highlight advancements in antibiotic combinations targeting multidrug-resistant pathogens and optimization of emergency department triage processes. He collaborates with international networks like the COVID-ICU group for pandemic-related critical care research.